BridgeMD
New treatment option for Aphakia
Official title Contralateral Claims Study of Clareon Vivity Pro
ClinicalTrials.gov ID: NCT07484191
What this study is testing
- What it's testing
- The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 22 and older
You may be able to join if
- Cataracts in both eyes.
- Preoperative corneal astigmatism of less than 1.00 diopter (D) in each eye.
- Potential postoperative best corrected visual acuity (BCDVA) of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
- Other protocol-defined may apply. Key
You likely can't join if
- Desires monovision correction.
- Predicted post-operative residual astigmatism of more than 1D in either eye.
- Any ocular or systemic co-morbidity that, in the investigator's medical opinion, may confound the results of this study, prohibit the completion of...
- Other protocol-defined exclusion criteria may apply.
The study team makes the final eligibility decision.
Where it's taking place
- Campsie, New South Wales, Australia
- Sydney, New South Wales, Australia
- Wollongong, New South Wales, Australia
- Woolloongabba, Queensland, Australia
- East Melbourne, Victoria, Australia
- Mornington, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Campsie, New South Wales, Australia; Sydney, New South Wales, Australia; Wollongong, New South Wales, Australia; Woolloongabba, Queensland, Australia; East Melbourne, Victoria, Australia; Mornington, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.